Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05388032 · ClinicalTrials.gov registry record · NA

Sodium Lowering Vascular Effects Trial

A NA study of Endothelial Dysfunction and Vascular Stiffness, sponsored by Tulane University.

Recruiting
Registry status
NA
Development phase
256
Enrollment target
1
Study location

NCT05388032 is a NA study of Endothelial Dysfunction and Vascular Stiffness that is actively recruiting participants, run by Tulane University. The registered enrollment target is 256 participants, above the 87-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (194% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05388032, a NA study of Endothelial Dysfunction and Vascular Stiffness, is actively recruiting participants, sponsored by Tulane University.

RECRUITING
Registry status
NA
Development phase
256 participants
Enrollment target
1
Study location

Study Summary

The proposed mechanistic trial will test the effect of dietary sodium reduction on cardiac and vascular structure and function in those with elevated blood pressure or hypertension. Findings from this study will fill the knowledge gap on the underlying mechanisms of dietary sodium intake on cardiovascular disease risk in addition to blood pressure and could provide further evidence on sodium reduction for the prevention of cardiovascular disease.

Interventions

  • BEHAVIORAL Sodium Reduction Intervention

Study Locations (1)

Louisiana

  • Tulane University Office of Health Research - New Orleans

Trial Details

FieldValue
Enrollment Target 256 participants
Start Date 2023-01-25
Est. Completion 2026-12-31
Phase NA

Sponsor

Tulane University

73 total trials

What the Registry Record Tells You About NCT05388032

The ClinicalTrials.gov registry entry for NCT05388032 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 87-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (194% higher). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Endothelial Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Sodium Reduction Intervention is the first listed.

NCT05388032 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT05388032 about?

NCT05388032 is a clinical study titled "Sodium Lowering Vascular Effects Trial". The proposed mechanistic trial will test the effect of dietary sodium reduction on cardiac and vascular structure and function in those with elevated blood pressure or hypertension. Findings from this study will fill the knowledge gap on the underlying mechanisms of dietary sodium intake on cardiova...

What is the current status of trial NCT05388032?

This trial is currently recruiting. It is a NA study. The enrollment target is 256 participants. The study started on 2023-01-25. Estimated completion is 2026-12-31.

What conditions does trial NCT05388032 study?

This clinical trial studies the following conditions: Endothelial Dysfunction, Vascular Stiffness, Left Ventricular Dysfunction, Left Ventricular Hypertrophy.

What interventions are being tested in trial NCT05388032?

The interventions under investigation include: Sodium Reduction Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05388032?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05388032 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endothelial Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.